Recent News
On February 6, 2026 nVent filed a Form 8‑K highlighting consecutive billion‑dollar sales quarters, expanded backlog and guidance for continued top‑line growth into 2026; the filing emphasized portfolio repositioning and operational capacity additions. On December 15, 2025 the Board approved a quarterly cash dividend of $0.21 per share, a 5% increase versus the prior quarterly payout, payable February 6, 2026. The company postponed then rescheduled its 2026 Investor Day after weather disruptions, with the event moved to March 18, 2026.
Technical Analysis
ADX at 20.17 registers an emerging trend strength and therefore validates directional signals without declaring a long, established trend; that emerging strength supports the case that recent upside retains conviction against the valuation backdrop.
DI+ registers 27.71 and shows an increasing trend while DI‑ registers 17.53 and trends down; the directional index structure therefore favors buyers and aligns with the immediate bullish price bias implied by moving averages.
MACD stands at 2.14 with the MACD line above the signal line (signal 1.86) and the MACD trend increasing; that crossover signals bullish momentum and reinforces continuation risk to the upside in the near term.
MRO reads 31.52 with a dip & reversal pattern; because the MRO sits positive, price currently sits above the implied target and faces mean‑reversion pressure that could trim gains if momentum weakens.
RSI registers 57.48 and shows an increasing trend; the RSI level sits below overbought thresholds and therefore supports further upside without an immediate overbought constraint.
Price closed at $121.80, trading above the 12‑ and 26‑day EMAs and above the 20‑, 50‑ and 200‑day averages (20‑day 115.05; 50‑day 109.47; 200‑day 93.54), which indicates trend alignment with current valuation and favors short‑term continuation.
Bollinger positioning shows price sitting slightly above the 2× upper band (upper 2× SD 121.17 vs price 121.80), signaling elevated short‑term volatility and greater likelihood of intraday consolidation or pullback compared with lower‑volatility periods.
Volume at 2,788,166 exceeds the 10‑day and 200‑day averages, underscoring conviction behind recent moves and supporting the momentum readings rather than signaling a hollow advance.
Fundamental Analysis
Reported EPS matched consensus at $0.90, producing an EPS surprise near 0.3% and signaling delivery in line with analyst expectations; forward EPS sits at $1.2028. QoQ and YoY dynamics show weakness in scaled earnings: earnings growth registers −1.10% on the latest metric, with earnings growth QoQ at −92.12% and earnings growth YoY at −82.69%, which reflect a markedly compressed near‑term earnings profile versus prior periods.
Revenue growth reads 0.0% on the headline metric while revenue growth QoQ and YoY both show −100.0% in the supplied series; those values indicate the reported growth metrics require close reconciliation with company disclosures but currently do not add fresh upside to valuation.
Price/earnings sits at 118.83 while forward P/E reads 84.93; the forward multiple compresses relative to the trailing P/E but remains elevated, reflecting high expectations priced into shares. WMDST values the stock as fair‑valued, which implies current multiples capture anticipated growth but leave limited margin for multiple expansion absent sustained earnings acceleration.
PEG registers −108.12, which falls well below the industry peer mean (about 6.56) and industry peer median (about 6.75) and lies outside the reported industry peer range (low −11.41, high 27.54); that placement sits beyond the peer range and therefore requires cautious interpretation rather than direct peer‑style benchmarking.
Company finance items show free cash flow improvement highlighted in recent filings and a low cost of debt near 0.95%, supporting capital allocation flexibility that underpinned the dividend increase announced in December 2025. WMDST’s fair valuation balances robust sales momentum and cash flow gains against elevated multiples and short‑term earnings variability.
MOST-RECENT QUARTERLY REPORT
| REPORT PERIOD ENDING: | 2025-12-31 |
| REPORT DATE: | 2026-02-06 |
| NEXT REPORT DATE: | 2026-05-08 |
| CASH FLOW | Begin Period Cash Flow | — |
| Operating Cash Flow | — | |
| Capital Expenditures | — | |
| Change In Working Capital | — | |
| Dividends Paid | — | |
| Cash Flow Delta | — | |
| End Period Cash Flow | — | |
| INCOME STATEMENT | REVENUE | |
| Total Revenue | — | |
| Forward Revenue | — | |
| COSTS | ||
| Cost Of Revenue | — | |
| Depreciation | — | |
| Depreciation and Amortization | — | |
| Research and Development | — | |
| Total Operating Expenses | — | |
| PROFITABILITY | ||
| Gross Profit | — | |
| EBITDA | — | |
| EBIT | — | |
| Operating Income | — | |
| Interest Income | — | |
| Interest Expense | — | |
| Net Interest Income | — | |
| Income Before Tax | — | |
| Tax Provision | — | |
| Tax Rate | — | |
| Net Income | — | |
| Net Income From Continuing Operations | — | |
| EARNINGS | ||
| EPS Estimate | $ 0.90 | |
| EPS Actual | $ 0.90 | |
| EPS Difference | $ 0.00 | |
| EPS Surprise | 0.31 % | |
| Forward EPS | $ 1.20 | |
| BALANCE SHEET | ASSETS | |
| Total Assets | — | |
| Intangible Assets | — | |
| Net Tangible Assets | — | |
| Total Current Assets | — | |
| Cash and Short-Term Investments | — | |
| Cash | — | |
| Net Receivables | — | |
| Inventory | — | |
| Long-Term Investments | — | |
| LIABILITIES | ||
| Accounts Payable | — | |
| Short-Term Debt | — | |
| Total Current Liabilities | — | |
| Net Debt | — | |
| Total Debt | — | |
| Total Liabilities | — | |
| EQUITY | ||
| Total Equity | — | |
| Retained Earnings | — | |
| VALUATION & PER-SHARE METRICS | EQUITY & PER-SHARE METRICS | |
| Book Value Per-Share | — | |
| Shares Outstanding | — | |
| Revenue Per-Share | — | |
| VALUATION | Market Capitalization | — |
| Enterprise Value | — | |
| Enterprise Multiple | — | |
| Enterprise Multiple QoQ | — | |
| Enterprise Multiple YoY | — | |
| Enterprise Multiple IPRWA | — | |
| EV/R | — | |
| CAPITAL STRUCTURE | ||
| Asset To Equity | — | |
| Asset To Liability | — | |
| Debt To Capital | — | |
| Debt To Assets | — | |
| Debt To Assets QoQ | — | |
| Debt To Assets YoY | — | |
| Debt To Assets IPRWA | — | |
| Debt To Equity | — | |
| Debt To Equity QoQ | — | |
| Debt To Equity YoY | — | |
| Debt To Equity IPRWA | — | |
| PRICE-BASED VALUATION | ||
| Price To Book (P/B) | — | |
| Price To Book QoQ | — | |
| Price To Book YoY | — | |
| Price To Book IPRWA | — | |
| Price To Earnings (P/E) | 118.827 | |
| Price To Earnings QoQ | -6.584 % | |
| Price To Earnings YoY | -0.393 % | |
| Price To Earnings IPRWA | high: 265.806 mean: 146.549 NVT: 118.827 median: 99.348 low: -66.062 |
|
| PE/G Ratio | -108.123 | |
| Price To Sales (P/S) | — | |
| Price To Sales QoQ | — | |
| Price To Sales YoY | — | |
| Price To Sales IPRWA | — | |
| FORWARD MULTIPLES | ||
| Forward P/E | 84.929 | |
| Forward PE/G | -77.278 | |
| Forward P/S | — | |
| EFFICIENCY | OPERATIONAL | |
| Operating Leverage | — | |
| ASSET & SALES | ||
| Asset Turnover Ratio | — | |
| Asset Turnover Ratio QoQ | — | |
| Asset Turnover Ratio YoY | — | |
| Asset Turnover Ratio IPRWA | — | |
| Receivables Turnover | — | |
| Receivables Turnover Ratio QoQ | — | |
| Receivables Turnover Ratio YoY | — | |
| Receivables Turnover Ratio IPRWA | — | |
| Inventory Turnover | — | |
| Inventory Turnover Ratio QoQ | — | |
| Inventory Turnover Ratio YoY | — | |
| Inventory Turnover Ratio IPRWA | — | |
| Days Sales Outstanding (DSO) | — | |
| CASH CYCLE | ||
| Cash Conversion Cycle Days (CCC) | — | |
| Cash Conversion Cycle Days QoQ | — | |
| Cash Conversion Cycle Days YoY | — | |
| Cash Conversion Cycle Days IPRWA | high: 614.837 median: 207.762 mean: 197.221 low: 85.997 NVT: 0 |
|
| CAPITAL DEPLOYMENT | ||
| Cash Conversion Ratio | — | |
| CapEx To Revenue | — | |
| CapEx To Depreciation | — | |
| CAPITAL, LIQUIDITY & COVERAGE | CAPITAL STRUCTURE | |
| Total Capital | — | |
| Net Invested Capital | — | |
| Invested Capital | $ 1.6 B | |
| Net Tangible Assets | — | |
| Net Working Capital | — | |
| LIQUIDITY | ||
| Cash Ratio | — | |
| Current Ratio | — | |
| Current Ratio QoQ | — | |
| Current Ratio YoY | — | |
| Current Ratio IPRWA | — | |
| Quick Ratio | — | |
| Quick Ratio QoQ | — | |
| Quick Ratio YoY | — | |
| Quick Ratio IPRWA | — | |
| COVERAGE & LEVERAGE | ||
| Debt To EBITDA | — | |
| Cost Of Debt | 0.95 % | |
| Interest Coverage Ratio | — | |
| Interest Coverage Ratio QoQ | — | |
| Interest Coverage Ratio YoY | — | |
| Interest Coverage Ratio IPRWA | — | |
| Operating Cash Flow Ratio | — | |
| TIMING / LIQUIDITY | ||
| Days Payables Outstanding (DPO) | — | |
| DIVIDENDS | ||
| Dividend Coverage Ratio | — | |
| Dividend Payout Ratio | — | |
| Dividend Rate | — | |
| Dividend Yield | — | |
| PERFORMANCE | GROWTH | |
| Asset Growth Rate | — | |
| Revenue Growth | 0.0 % | |
| Revenue Growth QoQ | -100.0 % | |
| Revenue Growth YoY | -100.0 % | |
| Revenue Growth IPRWA | high: 49.829 % mean: 11.451 % median: 7.631 % NVT: 0.0 % low: -64.129 % |
|
| Earnings Growth | -1.099 % | |
| Earnings Growth QoQ | -92.124 % | |
| Earnings Growth YoY | -82.69 % | |
| Earnings Growth IPRWA | high: 300.0 % mean: 44.939 % median: 5.556 % NVT: -1.099 % low: -128.571 % |
|
| MARGINS | ||
| Gross Margin | — | |
| Gross Margin QoQ | — | |
| Gross Margin YoY | — | |
| Gross Margin IPRWA | — | |
| EBIT Margin | — | |
| EBIT Margin QoQ | — | |
| EBIT Margin YoY | — | |
| EBIT Margin IPRWA | — | |
| Return On Sales (ROS) | — | |
| Return On Sales QoQ | — | |
| Return On Sales YoY | — | |
| Return On Sales IPRWA | — | |
| CASH FLOW | ||
| Free Cash Flow (FCF) | — | |
| Free Cash Flow Yield | — | |
| Free Cash Flow Yield QoQ | — | |
| Free Cash Flow Yield YoY | — | |
| Free Cash Flow Yield IPRWA | — | |
| Free Cash Growth | — | |
| Free Cash Growth QoQ | — | |
| Free Cash Growth YoY | — | |
| Free Cash Growth IPRWA | — | |
| Free Cash To Net Income | — | |
| Cash Flow Margin | 0.0 % | |
| Cash Flow To Earnings | 0.0 | |
| VALUE & RETURNS | ||
| Economic Value Added | — | |
| Return On Assets (ROA) | — | |
| Return On Assets QoQ | — | |
| Return On Assets YoY | — | |
| Return On Assets IPRWA | — | |
| Return On Capital Employed (ROCE) | — | |
| Return On Equity (ROE) | — | |
| Return On Equity QoQ | — | |
| Return On Equity YoY | — | |
| Return On Equity IPRWA | — | |
| DuPont ROE | — | |
| Return On Invested Capital (ROIC) | — | |
| Return On Invested Capital QoQ | — | |
| Return On Invested Capital YoY | — | |
| Return On Invested Capital IPRWA | — | |